GABA control of breathing and heart responses to low oxygen
GABA signaling in the nTS and cardiorespiratory responses to hypoxia
This project looks at whether weaker GABA inhibition in a brain area called the nTS makes breathing and heart reflexes overreact to repeated low-oxygen episodes, which could matter for people with sleep apnea.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11252769 on NIH RePORTER |
What this research studies
Researchers will use laboratory models of repeated low-oxygen exposure to study how inhibitory GABA signals in the nucleus tractus solitarii (nTS) change after chronic intermittent hypoxia. They will measure GABA release and receptor activity, examine chloride transporter balance (NKCC1 and KCC2), and test astrocyte GABA uptake pathways that could reduce inhibition. Techniques may include targeted viral tools, electrophysiology, and molecular methods to see how these changes affect nerve activity that controls breathing and heart responses. The goal is to map which GABA-related mechanisms shift the nTS toward overexcitation after repeated low-oxygen events.
Who could benefit from this research
Good fit: People with obstructive sleep apnea or other conditions causing repeated low-oxygen episodes would be the clinical group most likely to benefit, although the grant primarily performs laboratory research at the University of Missouri.
Not a fit: Patients whose symptoms are not related to intermittent hypoxia or who need immediate clinical treatment are unlikely to receive direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, the work could identify new molecular targets to reduce overactive breathing and cardiovascular reflexes in conditions like obstructive sleep apnea.
How similar studies have performed: Previous studies showed glutamate signaling becomes exaggerated after chronic intermittent hypoxia, but the role of GABA and related astrocyte transporters is less explored, so this is a novel extension of established findings.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Kline, David Douglas — University of Missouri-Columbia
- Study coordinator: Kline, David Douglas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.